Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-009773
Filing Date
2023-09-05
Accepted
2023-09-05 12:30:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27662
2 filename2.txt TEXT-EXTRACT 1502
  Complete submission text file 0000000000-23-009773.txt   40380
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filed for) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances